Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Scientific Papers of Interest
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Scientific Papers of Interest
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
2026 April
  • Home
  • Archive for April, 2026

Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism

  • April 22 2026

Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism (July 31, 2025) Abstract The human gut microbiota has the potential to synthesize proteins that may influence host metabolism. Here we report two polypeptides, RUMTOR-derived peptide (RORDEP) 1 and RORDEP2, circulating in human blood and synthesized by specific strains of gut commensal Ruminococcus torques that correlate inversely with

Continue Reading

RSS Industry News

  • The gut–joint axis in osteoarthritis May 7 2026
  • Surgically reshaping the gut microbiome May 7 2026
  • Comprehensive cross-cohort analysis reveals global gut microbiome signatures of celiac disease May 7 2026
  • Genome-wide sweeps create ecological units in the human gut microbiome May 6 2026
  • Practical lessons from microbiome citizen-science projects May 4 2026
  • Probiotics mitigate non-antibiotic drug-induced dysbiosis via protein homology-driven competitive binding May 4 2026
  • A Muribaculaceae-enriched microbiota exacerbates TLR4-dependent Acinetobacter baumannii-induced hyperinflammatory sepsis April 30 2026
  • Navigating the translational labyrinth of the gut microbiota April 29 2026
  • Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial April 27 2026
  • Community context reshapes microbial proteomes and reduces functional overlap April 24 2026
Quick Link
  • Products & Services
  • Blog
  • Contact
Recent Posts
  • Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism
  • Kailera Plans IPO for Obesity Drug That Could Top Lilly’s Zepbound
  • Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly
Sign up for our newsletter
Loading
Biosortia Microbiomics © 2026. All Rights Reserved.